Androgenic alopeciahttps://en.wikipedia.org/wiki/Pattern_hair_loss
Androgenic alopecia ndi kutayika kwa tsitsi komwe kumakhudza makamaka pamwamba ndi kutsogolo kwa scalp. Pakutayika kwa tsitsi lachimuna (MPHL), kutayika tsitsi kumadziwonetsa ngati mzere wakumbuyo wakumbuyo, kutayika kwa tsitsi pamutu pamutu, kapena kuphatikiza zonse ziwiri. Kutayika tsitsi kwachifanizo chachikazi (FPHL) nthawi zambiri kumawoneka ngati kuwonda kwa tsitsi lonse pamutu.

Kutayika kwa tsitsi lachimuna kumawoneka chifukwa cha kuphatikiza kwa majini ndi ma androgens ozungulira, makamaka dihydrotestosterone (DHT). Chomwe chimapangitsa tsitsi lachikazi kutayika sichikudziwika.

Thandizo lodziwika bwino limaphatikizapo minoxidil, finasteride, dutasteride, kapena opaleshoni yoika tsitsi. Kugwiritsiridwa ntchito kwa finasteride ndi dutasteride mwa amayi apakati kungayambitse zilema zobereka.

Machiritso
Finasteride ndi dutasteride ndizothandiza kwambiri kwa abambo ndi amayi omwe ali ndi vuto la postmenopausal. Mlingo wochepa wa oral minoxydil ukhoza kugwiritsidwa ntchito pazosankha zingapo.
#Finasteride
#Dutasteride

Chithandizo ― OTC Mankhwala
M'mayiko ambiri, topical minoxidil kukonzekera amapezeka pa-kauntala. Pali zowonjezera zina zomwe zimati zimagwira ntchito motsutsana ndi tsitsi, koma zambiri sizinatsimikizidwe mwasayansi kuti ndizothandiza.
#5% minoxidil
☆ Muzotsatira za 2022 Stiftung Warentest zochokera ku Germany, kukhutitsidwa kwa ogula ndi ModelDerm kunali kotsika pang'ono kusiyana ndi kuyankhulana kwa telemedicine komwe kulipiridwa.
  • Male-pattern hair loss
    References Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics 34741573 
    NIH
    Although topical minoxidil, oral finasteride, and low‐level light therapy are the only FDA‐approved therapies to treat AGA, they are just a fraction of the treatment options available, including other oral and topical modalities, hormonal therapies, nutraceuticals, PRP and exosome treatments, and hair transplantation.